Major drivers influencing adherence and quality of life during antiviral triple therapy in patients with chronic hepatitis C

1. WHO. (1999). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 6(1), 35-47.Search in Google Scholar

2. McHutchison, J.G., Manns, M.P., Muir, A.J., Terrault, N.A., Jacobson, I.M., Afdhal, N.H., Heathcote, E.J., Zeuzem, S., Reesink, H.W., Garg, J., Bsharat, M., George, S., Kauffman, R.S., Adda, N., Di Bisceglie, A.M. & Team, P.S. (2010). Telaprevir for previously treated chronic HCV infection. N Engl J Med. 362(14), 1292-1303. doi: 10.1056/NEJMoa0908014.10.1056/NEJMoa0908014Search in Google Scholar

3. Muir, A.J., Poordad, F.F., McHutchison, J.G., Shiffman, M.L., Berg, T., Ferenci, P., Heathcote, E.J., Pawlotsky, J.M., Zeuzem, S., Reesink, H.W., Dusheiko, G., Martin, E.C., George, S., Kauffman, R.S. & Adda, N. (2011). Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response. Hepatology. 54(5), 1538-1546. doi: 10.1002/hep.24549.10.1002/hep.24549Search in Google Scholar

4. Perry, C.M. (2012). Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C. Drugs. 72(5), 619-641. doi: 10.2165/11208370-000000000-00000.10.2165/11208370-000000000-00000Search in Google Scholar

5. Ascione, A. (2012). Boceprevir in chronic hepatitis C infection: a perspective review. Ther Adv Chronic Dis. 3(3), 113-121. doi: 10.1177/2040622312441496.10.1177/2040622312441496Search in Google Scholar

6. Leroy, V., Serfaty, L., Bourliere, M., Bronowicki, J.P., Delasalle, P., Pariente, A., Pol, S., Zoulim, F., Pageaux, G.P. & French Association for the Study of the, L. (2012). Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver. Liver Int. 32(10), 1477-1492. doi: 10.1111/j.1478-3231.2012.02856.x.10.1111/j.1478-3231.2012.02856.xSearch in Google Scholar

7. Matthews, S.J. & Lancaster, J.W. (2012). Telaprevir: a hepatitis C NS3/4A protease inhibitor. Clin Ther. 34(9), 1857-1882. doi: 10.1016/j.clinthera.2012.07.011.10.1016/j.clinthera.2012.07.011Search in Google Scholar

8. Claxton, A.J., Cramer, J. & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 23(8), 1296-1310.10.1016/S0149-2918(01)80109-0Search in Google Scholar

9. Buring, S.M., Winner, L.H., Hatton, R.C. & Doering, P.L. (1999). Discontinuation rates of Helicobacter pylori treatment regimens: a metaanalysis. Pharmacotherapy. 19(3), 324-332.10.1592/phco.19.4.324.30939Search in Google Scholar

10. Connor, J., Rafter, N. & Rodgers, A. (2004). Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ. 82(12), 935-939. doi: /S0042-96862004001200010.Search in Google Scholar

11. Iskedjian, M., Einarson, T.R., MacKeigan, L.D., Shear, N., Addis, A., Mittmann, N. & Ilersich, A.L. (2002). Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a metaanalysis. Clin Ther. 24(2), 302-316.10.1016/S0149-2918(02)85026-3Search in Google Scholar

12. Richter, A., Anton, S.F., Koch, P. & Dennett, S.L. (2003). The impact of reducing dose frequency on health outcomes. Clin Ther. 25(8), 2307-2335.10.1016/S0149-2918(03)80222-9Search in Google Scholar

13. Yildiz, A., Pauler, D.K. & Sachs, G.S. (2004). Rates of study completion with single versus split daily dosing of antidepressants: a metaanalysis. J Affect Disord. 78(2), 157-162.10.1016/S0165-0327(02)00300-2Search in Google Scholar

14. van Dulmen, S., Sluijs, E., van Dijk, L., de Ridder, D., Heerdink, R. & Bensing, J. (2007). Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 7, 55. doi: 10.1186/1472-6963-7-55.10.1186/1472-6963-7-55195582917439645Search in Google Scholar

15. Special report: interventions to improve patient adherence with medications for chronic cardiovascular disorders. (2003). TEC Bull (Online). 20(3), 30-32.Search in Google Scholar

16. DiMatteo, M.R. (2004). Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 42(3), 200-209.10.1097/01.mlr.0000114908.90348.f915076819Search in Google Scholar

17. Vergouwen, A.C., Bakker, A., Katon, W.J., Verheij, T.J. & Koerselman, F. (2003). Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 64(12), 1415-1420. 10.4088/JCP.v64n1203Search in Google Scholar